TRPM4 Modulates Right Ventricular Remodeling Under Pressure Load Accompanied With Decreased Expression Level.


Journal

Journal of cardiac failure
ISSN: 1532-8414
Titre abrégé: J Card Fail
Pays: United States
ID NLM: 9442138

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 28 04 2019
revised: 06 02 2020
accepted: 19 02 2020
pubmed: 10 3 2020
medline: 19 8 2021
entrez: 10 3 2020
Statut: ppublish

Résumé

Survival of patients with congenital heart defects including increased right ventricular pressure load (ie, tetralogy of Fallot) or pulmonary hypertension is dependent on the function of the right ventricle (RV). RV remodeling has several effects with progressive transition from compensated status to heart failure. Transient receptor potential melastatin 4 (TRPM4) forms cation channels expressed in myocardium, which was shown to modulate cardiac remodeling in the left ventricle of mice. Aim of this study was to identify the role of TRPM4 for contractile function and remodeling of the RV in a rat model of right ventricular pressure load. We performed experiments with untreated rats and under monocrotaline (MCT)-induced pressure load comparing wild-type (Trpm4 Right ventricular pressure load evoked by MCT treatment in rats leads to a prominent downregulation of TRPM4 protein expression in the RV and complete deletion of TRPM4 expression aggravates right ventricular hypertrophy. Thus, therapeutic modulation of TRPM4 expression and activity might represent a novel approach to target right ventricular remodeling in patients with pulmonary hypertension or otherwise loaded RV.

Sections du résumé

BACKGROUND BACKGROUND
Survival of patients with congenital heart defects including increased right ventricular pressure load (ie, tetralogy of Fallot) or pulmonary hypertension is dependent on the function of the right ventricle (RV). RV remodeling has several effects with progressive transition from compensated status to heart failure. Transient receptor potential melastatin 4 (TRPM4) forms cation channels expressed in myocardium, which was shown to modulate cardiac remodeling in the left ventricle of mice. Aim of this study was to identify the role of TRPM4 for contractile function and remodeling of the RV in a rat model of right ventricular pressure load.
METHODS AND RESULTS RESULTS
We performed experiments with untreated rats and under monocrotaline (MCT)-induced pressure load comparing wild-type (Trpm4
CONCLUSIONS CONCLUSIONS
Right ventricular pressure load evoked by MCT treatment in rats leads to a prominent downregulation of TRPM4 protein expression in the RV and complete deletion of TRPM4 expression aggravates right ventricular hypertrophy. Thus, therapeutic modulation of TRPM4 expression and activity might represent a novel approach to target right ventricular remodeling in patients with pulmonary hypertension or otherwise loaded RV.

Identifiants

pubmed: 32147520
pii: S1071-9164(19)30440-3
doi: 10.1016/j.cardfail.2020.02.006
pii:
doi:

Substances chimiques

TRPM Cation Channels 0
TRPM4 protein, human 0
TRPM4 protein, mouse 0
TRPM4 protein, rat 0
Monocrotaline 73077K8HYV

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

599-609

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Wiebke Frede (W)

Department Pediatric and Congenital Cardiology, University Medical Center, Heidelberg, Germany; Institute of Pharmacology, University Medical Center, Heidelberg, Germany.

Rebekka Medert (R)

Institute of Pharmacology, University Medical Center, Heidelberg, Germany.

Tanja Poth (T)

Center for Model System and Comparative Pathology, University Medical Center, Heidelberg, Germany.

Matthias Gorenflo (M)

Department Pediatric and Congenital Cardiology, University Medical Center, Heidelberg, Germany.

Rudi Vennekens (R)

Laboratory of Ion Channel Research, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Vlaams Brabant, Belgium.

Marc Freichel (M)

Institute of Pharmacology, University Medical Center, Heidelberg, Germany.

Sebastian Uhl (S)

Department Pediatric and Congenital Cardiology, University Medical Center, Heidelberg, Germany; Institute of Pharmacology, University Medical Center, Heidelberg, Germany. Electronic address: sebastian.uhl@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH